Wnt signaling suppresses MAPK-driven proliferation of intestinal stem cells.

Abstract

Intestinal homeostasis depends on a slowly proliferating stem cell compartment in crypt cells, followed by rapid proliferation of committed progenitor cells in the transit amplifying (TA) compartment. The balance between proliferation and differentiation in intestinal stem cells (ISCs) is regulated by Wnt/β-catenin signaling, although the mechanism remains unclear. We previously targeted PORCN, an enzyme essential for all Wnt secretion, and demonstrated that stromal production of Wnts was required for intestinal homeostasis. Here, a PORCN inhibitor was used to acutely suppress Wnt signaling. Unexpectedly, the treatment induced an initial burst of proliferation in the stem cell compartment of the small intestine, due to conversion of ISCs into TA cells with a loss of intrinsic ISC self-renewal. This process involved MAPK pathway activation, as the proliferating cells in the base of the intestinal crypt contained phosphorylated ERK1/2, and a MEK inhibitor attenuated the proliferation of ISCs and their differentiation into TA cells. These findings suggest a role for Wnt signaling in suppressing the MAPK pathway at the crypt base to maintain a pool of ISCs. The interaction between Wnt and MAPK pathways in vivo has potential therapeutic applications in cancer and regenerative medicine.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1172/jci99325

Publication Info

Kabiri, Zahra, Gediminas Greicius, Hamed Zaribafzadeh, Amanda Hemmerich, Christopher M Counter and David M Virshup (2018). Wnt signaling suppresses MAPK-driven proliferation of intestinal stem cells. The Journal of clinical investigation, 128(9). pp. 3806–3812. 10.1172/jci99325 Retrieved from https://hdl.handle.net/10161/31636.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Kabiri

Zahra Kabiri

Assistant Professor in Surgery
Counter

Christopher M. Counter

George Barth Geller Distinguished Professor of Pharmacology

The Counter lab studies the molecular mechanisms that underly to the onset of human cancers, with the goal to prevent cancer initiation or progression.  The lab uses ultra-senstitive sequencing platforms and proteomic-coupled CRISPR/Cas9 screens to elucidate the factors that mold the mutational patterns selected to initiate the process of tumorigenesis.  See https://counter.labs.duke.edu/ for further details.

Virshup

David Marc Virshup

Professor of Pediatrics

Wnt Signaling and Cancer Biology; Circadian Rhythms; Pediatric Hematology/Oncology


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.